FDA requires opioid manufacturers to provide mail-back disposal option

Tyler Patchen

News Reporter

Many Americans access unused opioids from friends or relatives after surgical procedures, according to the FDA. The agency is looking to change that with a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA requires opioid manufacturers to provide mail-back disposal option

Tyler Patchen

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Sanofi's BTK inhibitor again slows MS progression, but liver enzymes continue to be tricky

Lexicon's president to step down as decision date looms; Sarepta welcomes Lilly, GSK vet to board

Gilead's Kite uncouples from Fosun in China as Yescarta faces coverage obstacles

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Breaking down silos with a new quantitative approach to drug development

FDA re­quires opi­oid man­u­fac­tur­ers to pro­vide mail-back dis­pos­al op­tion

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

FDA requires opioid manufacturers to provide mail-back disposal option